| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
10,532 |
7,831 |
$1.12M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
456 |
354 |
$141.32 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
183 |
109 |
$0.00 |
| 3078F |
|
86 |
75 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
88 |
83 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
454 |
356 |
$0.00 |
| 99201 |
|
108 |
83 |
$0.00 |
| 81003 |
|
154 |
134 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
28 |
28 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
704 |
543 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
295 |
242 |
$0.00 |
| 87428 |
|
865 |
800 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,193 |
4,771 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
54 |
50 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
121 |
106 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
31 |
28 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
56 |
55 |
$0.00 |
| 3074F |
|
87 |
76 |
$0.00 |